New Drug Launches Coupled with Increasing Use of E-Cigarettes Globally Is Expected to Propel the Growth of the Global Anti-Asthmatic Drugs Market

The global anti-asthmatic drugs market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). Asthma is a chronic disease that affects a number of people across the globe including children. Most of the prominent pharmaceutical companies are included in developing various type of drugs for asthma. Probiotics are gaining popularity in the market for treatment for asthma in the patients. Probiotics can improve the immune system through the gut ecosystem and can be useful in treating illnesses such as asthma. For instance, in November 2020, Activated Probiotics, an Australian company that manufactures leading probiotic products, announced that it was expanding its range and developing probiotic products for the treatment of asthma.

Browse the full report description of “Global Anti-Asthmatic Drugs Market Size, Share & Trends Analysis Report by Type (Long-term Control Medications, Quick-relief Medication and Medications for Allergy-induced Asthma), by Material (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) Forecast 2022-2028” at https://www.omrglobal.com/industry-reports/biotechnology-reagent-market

Besides, the anti-asthmatics drug market is driving by increasing development of bioelectric drugs to treat asthma patients. Bioelectronic Medicine focuses on electrical signaling in the nervous system to deal with a wide range of chronic diseases using small, artificial devices that can convert electrical signals through nerves in the body, including abnormal or altered sensations that occur in many diseases. For Instance, in July 2020, electroCore Inc., a US company based on bioelectronic medicine, received FDA approval for a neurotransmitter in patients with asthma it may have been exposed to the novel coronavirus.

Additionally, E-cigarettes, which is a substitute of direct tobacco smoking is increasing in popularity. E-cigarette smoking increases the risk of asthma among people as it contains nicotine extracts from cigarettes. E-cigarettes are also known as e-cigs, vaporizer cigarettes, and vape pens that are battery-powered tools that emit volatile nicotine doses, or non-nicotine solutions to give the user a similar sense of smell in cigarette smoke. Increased adoption of e-cigs is rising the number of patients with asthma which in turn is expected to boost the anti-asthmatics drug market during the forecast period.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Type
• By Application 

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape- including Novartis International AG, Sanofi SA, Regeneron Pharmaceuticals Inc., and others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

oDeviation from the pre-COVID-19 forecast

oMost affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Anti-Asthmatic Drugs Market Report Segment

By Type

• Long-term Control Medications
• Quick-relief Medications (Rescue Medications)
• Medications for Allergy-induced Asthma

By Application

• Hospital Pharmacy
• Retails Pharmacy
• Online Pharmacy

Global Anti-Asthmatic Drugs Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/anti-asthmatic-drugs-market